Hypercalcemia in post Stem Cell Transplant setting - A case report and review of literature

Nemani Sandeep Anil .

Abstract


Hypercalcemia is not uncommon with various hematological and non hematological malignancies. Here we report a 20 year old male who was diagnosed to have primary myelofibrosis (PMF) which later transformed to acute myeloid leukemia. He underwent haploidentical allogeneic stem cell transplant (SCT) for the same. He developed symptomatic hypercalcemia on day 18 post transplant. Hypercalcemia in post SCT settings is a well known fact in cases of Osteopetrosis where engraftement of donor derived osteoclasts causes transient hypercalcemia in early SCT period.

Full Text:

PDF

References


Stewart AF. Clinical practice. Hypercalcemia associated with cancer. The New England journal of medicine. 2005;352(4):373-9. Epub 2005/01/28.

Clines GA, Guise TA. Hypercalcaemia of malignancy and basic research on mechanismsre- sponsible for osteolytic and osteoblastic metastasis to bone. Endocrine-related cancer. 2005;12(3): 549-83. Epub 2005/09/21.

Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289(5484):1504-8. Epub2000/09/01.

Martinez C, Polgreen LE, DeFor TE, Kivisto T, Petryk A, Tolar J, et al. Characterization andmanagement of hypercalcemia following transplantation for osteopetrosis. Bone marrow transplantation. 2010;45 (5):939-44. Epub 2009/10/06.

Lataillade JJ, Pierre-Louis O, Hasselbalch HC, Uzan G, Jasmin C, Martyre MC, et al. Doesprimary myelofibrosis involve a defective stem cell niche? From concept to evidence. Blood. 2008;112(8): 3026-35. Epub 2008/08/02.

Bock O, Loch G, Schade U, Busche G, Wasielewski R, Wiese B, et al. Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression ofosteoprotegerin. British journal of haematology. 2005;130 (1):76-82. Epub 2005/06/29.

Chagraoui H, Tulliez M, Smayra T, Komura E, Giraudier S, Yun T, et al. Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. Blood.2003;101(8):2983-9. Epub 2002/12/31.

Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, et al. Osteoprotegerinproduced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology. 2000;141(9):3478-84. Epub 2000/08/31.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An initiative of The Tamil Nadu Dr M.G.R. Medical University